These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 15026550)
1. The cyclooxygenase-2 inhibitor celecoxib blocks phosphorylation of Akt and induces apoptosis in human cholangiocarcinoma cells. Wu T; Leng J; Han C; Demetris AJ Mol Cancer Ther; 2004 Mar; 3(3):299-307. PubMed ID: 15026550 [TBL] [Abstract][Full Text] [Related]
2. Celecoxib acts in a cyclooxygenase-2-independent manner and in synergy with emodin to suppress rat cholangiocarcinoma growth in vitro through a mechanism involving enhanced Akt inactivation and increased activation of caspases-9 and -3. Lai GH; Zhang Z; Sirica AE Mol Cancer Ther; 2003 Mar; 2(3):265-71. PubMed ID: 12657721 [TBL] [Abstract][Full Text] [Related]
3. Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation. Zhang Z; Lai GH; Sirica AE Hepatology; 2004 Apr; 39(4):1028-37. PubMed ID: 15057907 [TBL] [Abstract][Full Text] [Related]
4. The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. Hsu AL; Ching TT; Wang DS; Song X; Rangnekar VM; Chen CS J Biol Chem; 2000 Apr; 275(15):11397-403. PubMed ID: 10753955 [TBL] [Abstract][Full Text] [Related]
5. Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9. Ding H; Han C; Zhu J; Chen CS; D'Ambrosio SM Int J Cancer; 2005 Feb; 113(5):803-10. PubMed ID: 15499625 [TBL] [Abstract][Full Text] [Related]
6. Proapoptotic and antiproliferative potential of selective cyclooxygenase-2 inhibitors in human liver tumor cells. Kern MA; Schubert D; Sahi D; Schöneweiss MM; Moll I; Haugg AM; Dienes HP; Breuhahn K; Schirmacher P Hepatology; 2002 Oct; 36(4 Pt 1):885-94. PubMed ID: 12297835 [TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602 [TBL] [Abstract][Full Text] [Related]
8. Anti-gastric cancer effects of celecoxib, a selective COX-2 inhibitor, through inhibition of Akt signaling. Kim N; Kim CH; Ahn DW; Lee KS; Cho SJ; Park JH; Lee MK; Kim JS; Jung HC; Song IS J Gastroenterol Hepatol; 2009 Mar; 24(3):480-7. PubMed ID: 18823436 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines. Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245 [TBL] [Abstract][Full Text] [Related]
10. Using cyclooxygenase-2 inhibitors as molecular platforms to develop a new class of apoptosis-inducing agents. Zhu J; Song X; Lin HP; Young DC; Yan S; Marquez VE; Chen CS J Natl Cancer Inst; 2002 Dec; 94(23):1745-57. PubMed ID: 12464646 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells. Dandekar DS; Lopez M; Carey RI; Lokeshwar BL Int J Cancer; 2005 Jun; 115(3):484-92. PubMed ID: 15688368 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of cyclooxygenase-2 (COX-2) in human primitive neuroectodermal tumors: effect of celecoxib and rofecoxib. Patti R; Gumired K; Reddanna P; Sutton LN; Phillips PC; Reddy CD Cancer Lett; 2002 Jun; 180(1):13-21. PubMed ID: 11911965 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of cyclooxygenase-2 in human HepG2, Bel-7402 and SMMC-7721 hepatoma cell lines and mechanism of cyclooxygenase-2 selective inhibitor celecoxib-induced cell growth inhibition and apoptosis. Liu NB; Peng T; Pan C; Yao YY; Shen B; Leng J World J Gastroenterol; 2005 Oct; 11(40):6281-7. PubMed ID: 16419156 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells. Levitt RJ; Pollak M Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway. Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467 [TBL] [Abstract][Full Text] [Related]
17. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. He Q; Luo X; Huang Y; Sheikh MS Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115 [TBL] [Abstract][Full Text] [Related]
18. Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: role of COX-2 and MDR-1. Arunasree KM; Roy KR; Anilkumar K; Aparna A; Reddy GV; Reddanna P Leuk Res; 2008 Jun; 32(6):855-64. PubMed ID: 18083230 [TBL] [Abstract][Full Text] [Related]
19. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]